Business / Finance

RSS

Mazor Robotics to be included in TASE Top 75 Index and Top 100 Index from Dec 15, 2013

Mazor Robotics Ltd., the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that it will be included in both the Tel Aviv Stock Exchange (TASE) Top 75 Index (TA-75) and Top 100 Index (TA-100), effective December 15, 2013.

12 Dec 2013

Eastern Technologies merges with Global Resources International

Generational Equity, a leading mergers and acquisitions advisor for privately-held, middle-market businesses, is pleased to announce the merger of its client, Eastern Technologies, Inc., headquartered in Ashford, Alabama, with Global Resources International, Inc., headquartered in Flowery Branch, Georgia.

12 Dec 2013

Senhwa Biosciences raises additional $17 million USD in Series B financing

Senhwa Biosciences, Inc. has raised an additional $17 million USD in a Series B financing to drive its anticancer agents through critical clinical trials, the company announced today.

12 Dec 2013

ZEISS reports record revenue in fiscal year 2012/13

ZEISS has brought fiscal year 2012/13 to a successful conclusion (reporting date: 30 September 2013) with a new record high in revenue. The company generated revenue totaling EUR 4.190 billion (prior year: EUR 4.163 billion) and earnings (EBIT) of EUR 335 million (prior year: EUR 420 million).

12 Dec 2013

Synthetic Biologics prices underwritten public offering of common stock at $1.00 per share

Synthetic Biologics, Inc., a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today the pricing of an underwritten public offering of 11,500,000 shares of common stock at a public offering price of $1.00 per share.

12 Dec 2013

Endo Finance prices $700 million aggregate principal amount of 5.75% senior unsecured notes

Endo Health Solutions ("Endo") today announced that Endo Finance Co., its wholly-owned subsidiary ("Endo Finance"), priced $700 million aggregate principal amount of 5.75% senior unsecured notes due January 2022 at an issue price of $1,000 per $1,000 principal amount (the "notes") in connection with its previously announced private offering.

12 Dec 2013

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions Inc.announced that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million.

12 Dec 2013

Avinger closes significant funding round to initiate clinical trial on peripheral atherectomy catheter

Avinger, Inc. producer of therapeutic devices incorporating intravascular imaging and pioneer of the lumivascular approach to treating vascular disease, announced today the closing of a significant funding round.

12 Dec 2013

Crealta to acquire all assets of Savient Pharmaceuticals

Savient Pharmaceuticals, Inc. ("Savient") announced that it has reached agreement on the terms of an acquisition agreement with Crealta Pharmaceuticals LLC ("Crealta") through which Crealta would acquire substantially all of the assets of Savient, including all KRYSTEXXA® assets, for gross proceeds of approximately $120.4 million.

11 Dec 2013

Pfizer, Octapharma AG to market investigational agent for urgent reversal of vitamin K antagonist

...

11 Dec 2013

Vestiage selects ROI Media for direct to consumer marketing campaign

Vestiage, Inc., a publicly traded healthy aging lifestyle company focused on science-based premium branded highly potent cosmeceuticals and nutraceuticals, announced today that it has engaged ROI Media to orchestrate its direct to consumer marketing campaign.

11 Dec 2013

Broad Medical Research Program, Crohn's & Colitis Foundation of America to merge together

The Broad Medical Research Program, which funds innovative early-stage research into inflammatory bowel disease, will merge with the Crohn's & Colitis Foundation of America, the two organizations announced today.

11 Dec 2013

Patterson Companies announces quarterly cash dividend of $0.16 per share

The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.

11 Dec 2013

Omega Protein proposes to streamline Gulf of Mexico operations

Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today announced a plan to streamline its Gulf of Mexico operations and increase efficiencies through the permanent closure of the Company's menhaden fish processing plant located in Cameron, Louisiana and the redeployment of certain vessels from that plant.

11 Dec 2013

LEC announces consolidated financial results for Q2 2014

Lignol Energy Corporation ("LEC" or "the Company"), a leading technology company in the advanced biofuels and renewable chemicals sector, today announced its unaudited consolidated financial results for the three months and six months ended October 31, 2013 (all figures in Canadian dollars, unless otherwise noted).

11 Dec 2013

Echo Therapeutics signs strategic collaboration agreement with MTIA

Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.

10 Dec 2013

INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.

10 Dec 2013

Methodist Health System joins with IBM Watson and MD Buyline to enable better patient care

Methodist Health System, a premier healthcare provider in the Dallas-Fort Worth area, will leverage MD Buyline's Hippocrates powered by IBM Watson (a cognitive computing application) in its hospitals to enable better patient care, satisfaction and outcomes through more informed decision making.

10 Dec 2013

Adocia gets development and commercialization rights in nanotechnology for drug delivery

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today the signature of an exclusive license agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science Transfert.

9 Dec 2013

Atonomics reaches agreement to advance development of diagnostic test for lifestyle diseases

Atonomics announces today that it has entered into an agreement with Omron Healthcare, which will enable Atonomics to advance the development of the AtolyzerConsumer device for advanced diagnostic testing of lifestyle diseases in a consumer pharmacy setting. As part of the transaction Omron Healthcare is taking a minority equity stake in Atonomics.

9 Dec 2013

Business / Finance

Mazor Robotics to be included in TASE Top 75 Index and Top 100 Index from Dec 15, 2013

Eastern Technologies merges with Global Resources International

Senhwa Biosciences raises additional $17 million USD in Series B financing

ZEISS reports record revenue in fiscal year 2012/13

Synthetic Biologics prices underwritten public offering of common stock at $1.00 per share

Endo Finance prices $700 million aggregate principal amount of 5.75% senior unsecured notes

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Avinger closes significant funding round to initiate clinical trial on peripheral atherectomy catheter

Crealta to acquire all assets of Savient Pharmaceuticals

Pfizer, Octapharma AG to market investigational agent for urgent reversal of vitamin K antagonist

Vestiage selects ROI Media for direct to consumer marketing campaign

Broad Medical Research Program, Crohn's & Colitis Foundation of America to merge together

Patterson Companies announces quarterly cash dividend of $0.16 per share

Omega Protein proposes to streamline Gulf of Mexico operations

LEC announces consolidated financial results for Q2 2014

Echo Therapeutics signs strategic collaboration agreement with MTIA

INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

Methodist Health System joins with IBM Watson and MD Buyline to enable better patient care

Adocia gets development and commercialization rights in nanotechnology for drug delivery

Atonomics reaches agreement to advance development of diagnostic test for lifestyle diseases

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News